Using “old” medications to fight new COVID-19: Re-purposing with a purpose
When the COVID-19 pandemic first emerged at the end of 2019, there were many speculations about the potential impact and course of progression, but none would have imagined the speed and the scale of its spread and devastation to people's lives and livelihood across the global [1,2]. Despite the unprecedented efforts and rapid scientific progress in the discovery of the cellular and molecular details for the pathogenesis of COVID-19 as a result of SARS-COV2 infection, there are still no specific new therapies that have been approved to either prevent or treat COVID19 in clinics [1,2].
Source: Journal of Molecular and Cellular Cardiology - Category: Cytology Authors: Yibin Wang, Roger Foo, Thomas Thum Tags: Letter to the editor Source Type: research